Review
Copyright ©The Author(s) 2025.
World J Diabetes. Jun 15, 2025; 16(6): 106720
Published online Jun 15, 2025. doi: 10.4239/wjd.v16.i6.106720
Table 3 The role of iron metabolism dysregulation in diabetic osteoporosis
Mechanism type
Key factors
Pathway
Impact on bone metabolism
Ref.
Iron overloadIron ions (Fe2+/Fe3+)Excess iron generates ROS via the Fenton reaction, causing oxidative stress and lipid peroxidationDamages osteoblasts, inhibits their differentiation and function, reduces bone formation; promotes osteoclast differentiation, increasing bone resorptionZang et al[59], Liu et al[62], Harrison et al[65]
Ferroptosis (iron-dependent cell death)GPX4, SLC7A11, ROSIron-dependent cell death involving lipid peroxidation and antioxidant system imbalanceInduces bone cell death, disrupts bone tissue structure, and promotes the progression of osteoporosisYang et al[68]
Hepcidin dysregulationHepcidin, FPN1Overexpression of hepcidin inhibits iron export protein FPN1, leading to intracellular iron accumulationIncreases iron content in bone marrow mesenchymal stem cells, inhibits their differentiation into osteoblasts, reduces bone formationZang et al[59]
Hyperglycemia-induced dysregulationHyperglycemia, AGEs, ROSHigh-glucose environment promotes AGEs formation; AGEs bind to their receptors, inducing ROS production and iron metabolism dysregulationCauses osteoblast dysfunction, enhances osteoclast activity, and exacerbates osteoporosisXie et al[71], Dludla et al[72], Zhao et al[73]